Nucleoside Reverse Transcriptase Inhibitor
Showing 1 - 25 of 9,363
HIV, Bariatric Surgery Candidate Trial (bariatric surgery)
Not yet recruiting
- HIV Infections
- Bariatric Surgery Candidate
- bariatric surgery
- (no location specified)
Sep 9, 2022
HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease
Active, not recruiting
- HIV-1 Infection
- Doravirine, Tenofovir, Lamivudine
- +4 more
- (no location specified)
Sep 2, 2022
HIV-1-infection Trial in Johannesburg (Doravirine/Lamivudine/Tenofovir)
Recruiting
- HIV-1-infection
-
Johannesburg, Gauteng, South Africa
- +2 more
Jun 6, 2022
HIV-1 Infection Trial (Doravirine/lamivudine/tenofovir disoproxil fumarate)
Completed
- HIV-1 Infection
- Doravirine/lamivudine/tenofovir disoproxil fumarate
- (no location specified)
Oct 7, 2021
HIV Trial in United States (Raltegravir (MK-0518), Placebo)
Completed
- HIV Infections
- Raltegravir (MK-0518)
- Placebo
-
Birmingham, Alabama
- +19 more
Nov 2, 2021
HIV-1 Infection Trial in France (Samplings)
Recruiting
- HIV-1 Infection
- Samplings
-
Clamart, France
- +6 more
Jan 4, 2022
HIV Trial in Worldwide (DTG, LPV/RTV, Two NRTIs)
Completed
- HIV Infections
- DTG
- +2 more
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
- +58 more
Feb 23, 2022
Single Versus Double Ritonavir-boosted Protease Inhibitor-Based
Completed
- HIV Infection
- HIV Infections
- ritonavir-boosted PI-based second line treatments
- two PIs boosted by low dose ritonavir or one PI plus full dose ritonavir
-
Bangkok, Thailand
- +7 more
Jul 15, 2020
Third Line Highly Active Antiretroviral Therapy in HIV-infected
Completed
- This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy
-
Bangkok, Thailand
- +8 more
Jul 15, 2020
Maternal-fetal Infection Transmission Trial in France (darunavir monotherapy)
Completed
- Maternal-fetal Infection Transmission
- darunavir monotherapy
-
Argenteuil, France
- +22 more
Aug 5, 2021
HIV Trial in Worldwide (GSK3640254, ABC/3TC, FTC/TAF)
Active, not recruiting
- HIV Infections
- GSK3640254
- +4 more
-
Los Angeles, California
- +65 more
Jul 18, 2022
Effect on HIV Medications on EPC Cells
Completed
- AIDS
- Tenofovir
- +3 more
-
Washington, District of ColumbiaThe GW Medical Faculty Associates
Mar 21, 2022
HIV Trial in United States (Atevirdine mesylate, Zidovudine, Didanosine)
Completed
- HIV Infections
- Atevirdine mesylate
- +2 more
-
Los Angeles, California
- +4 more
Oct 27, 2021
Aicardi Goutières Syndrome Trial in Philadelphia (Tenofovir (TDF) and Emtricitabine (FTC), Placebo)
Not yet recruiting
- Aicardi Goutières Syndrome
- Tenofovir (TDF) and Emtricitabine (FTC)
- Placebo
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Feb 8, 2022
Chronic HBV Infection Trial in China (Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003,
Recruiting
- Chronic HBV Infection
- Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
- +2 more
-
Beijing, Beijing, China
- +7 more
Feb 23, 2023
Bictegravir in the Elderly Living With HIV (BICEP)
Active, not recruiting
- HIV-1-infection
- Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
-
Buffalo, New YorkEvergreen Health
Oct 28, 2022
HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Efavirenz)
Completed
- HIV Infections
- Indinavir sulfate
- +2 more
-
Los Angeles, California
- +55 more
Oct 28, 2021